Evidence map›Paper›PMID 33048925›Full record

ArticlePLoS neglected tropical diseases2020

Dried blood spot cards: A reliable sampling method to detect human antibodies against rabies virus.

Laura Doornekamp, Carmen W E Embregts, Georgina I Aron, Simone Goeijenbier, David A M C van de Vijver, Eric C M van Gorp, Corine H GeurtsvanKessel

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. RSV Neutralizing Antibodies in Dried Blood.The Journal of infectious diseases · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Laura DoornekampDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, WHO Collaborating Centre-Emerging Viral Infections, Rotterdam, the Netherlands.ORCID 0000-0002-6525-6002
Carmen W E EmbregtsDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, WHO Collaborating Centre-Emerging Viral Infections, Rotterdam, the Netherlands.ORCID 0000-0003-4710-9225
Georgina I AronDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, WHO Collaborating Centre-Emerging Viral Infections, Rotterdam, the Netherlands.
Simone GoeijenbierDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, WHO Collaborating Centre-Emerging Viral Infections, Rotterdam, the Netherlands.
David A M C van de VijverDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, WHO Collaborating Centre-Emerging Viral Infections, Rotterdam, the Netherlands.
Eric C M van GorpDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, WHO Collaborating Centre-Emerging Viral Infections, Rotterdam, the Netherlands.
Corine H GeurtsvanKesselDepartment of Viroscience, Erasmus MC, University Medical Center Rotterdam, WHO Collaborating Centre-Emerging Viral Infections, Rotterdam, the Netherlands.
Erasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough preventable by vaccination for more than a century, rabies virus still causes numerous fatalities every year. To determine antibody levels in humans, blood collected with a finger prick and applied on dried blood spot (DBS) cards is an alternative for venipuncture. The use of DBS is specifically valuable in remote areas, as it is easy to perform, store and transport. Therefore, the technique is frequently used for epidemiological studies of tropical diseases. Up to present, determination of rabies virus antibody levels on human DBS has not been validated. METHODOLOGY/PRINCIPAL

findingsWe evaluated the use of human DBS for rabies serology and analyzed 99 pre- or post-vaccination serum and DBS samples with a fluorescent antibody virus neutralization test (FAVNt), which is the gold standard to detect protective antibody levels, and a Bio-Rad Platelia Rabies II ELISA. Sensitivity and specificity of DBS eluates tested with the FAVNt were 97% and 92%, respectively and 87% and 96% when tested with the Platelia-II ELISA. Antibody levels measured in serum with the FAVNt, correlated best with antibody levels measured in DBS with the FAVNt (R = 0.88). CONCLUSIONS/SIGNIFICANCE: This is the first study that applies DBS for reliable detection of human antibodies against rabies virus. Both the FAVNt and Platelia-II ELISA demonstrate an acceptable performance on DBS, providing opportunities for rabies serology in remote areas. This technique could drastically ease studies evaluating (novel) rabies vaccination strategies and monitoring persisting immunity in humans at risk, living in rabies endemic regions.

Indexed as

Antibodies, ViralDried Blood Spot TestingHumansRabiesRabies virusSensitivity and SpecificityAntibodies, Viral

Identifiers

PMID33048925
PMCPMC7584180
OpenAlexW3092259704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.